News

The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...
Clinical ink has launched the AI-powered, fully integrated analytics dashboard, TrialLens, which is designed to interpret ...
The trial’s secondary and exploratory objectives include the duration of ventilator use and the need for blood products. Credit: MAD.vertise / Shutterstock. Renibus Therapeutics has completed subject ...
At ESCMID 2025, early data suggest that Assembly Biosciences’ ABI-5366 could redefine the treatment landscape for recurrent genital herpes (RGH).
Sanofi will halt the development of its oral tumour necrosis factor (TNF) inhibitor balinatunfib as a monotherapy after it ...
Tiziana Life Sciences has announced the commencement of dosing in the fourth clinical site of the company’s Phase II trial of ...
Akeso and Summit's drug previously beat Keytruda in a separate Phase III study, extending PFS by five months. Akeso ...
Lokavant has launched the AI-powered clinical trial forecasting solution, Spectrum v15, to dispel uncertainty in the ...
EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved since the 1990s.
According to the WHO, meningitis is a significant global health threat even though treatments and vaccines against some forms are available.